1,990
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

The feasibility and outcome of a community-based primary prevention program for cardiovascular disease in the 21st century

, , , &
Pages 157-165 | Received 17 Nov 2020, Accepted 25 Jan 2021, Published online: 07 Jun 2021

References

  • WHO. WHO fact sheet the top 10 causes of death. 2019. [Accessed 10 Sep 2019]. Available at: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death
  • Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2019;6736:1–14.
  • Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev. 2019;1:CD009009.
  • Jousilahti P, Laatikainen T, Salomaa V, et al. 40-Year CHD mortality trends and the role of risk factors in mortality decline: the North Karelia project experience. Glob Heart. 2016;11(2):207–212.
  • Berg J, Björck L, Lappas G, et al. Continuing decrease in coronary heart disease mortality in Sweden. BMC Cardiovasc Disord. 2014;14:9.
  • Aspelund T, Gudnason V, Magnusdottir BT, et al. Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One. 2010;5(11):e13957.
  • Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001;30(3):427–432.
  • Cooney MT, Dudina A, Whincup P, et al.; SCORE Investigators. Re-evaluating the rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil. 2009;16(5):541–549.
  • Korhonen P, Aarnio P, Saaresranta T, et al. Glucose homeostasis in hypertensive subjects. Hypertension. 2008;51(4):945–949.
  • Lindström J, Tuomilehto J. The Diabetes Risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725–731.
  • Alberti KGMM, Zimmet P, Shaw J. for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366(9491):1059–1062.
  • Conroy RM, Pyörälä K, Fitzgerald AP, et al.; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J. 2003;24(11):987–1003.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
  • Babor T, de la Fuente J, Saunders J, et al. AUDIT: the alcohol use disorders identification test: guidelines for use in primary healthcare. WHO/MNH/DAT 89.4. Geneva: World Health Organization; 1989.
  • Beck A, Rush A, Shaw B, et al. Cognitive therapy of depression. New York: Guilford Press; 1979.
  • Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33(5):350–357.
  • Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, et al. Depressive symptoms and 10-year risk for cardiovascular morbidity and mortality. World J Biol Psychiatry. 2010;11(6):834–839.
  • Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. 2006. [Accessed 19 Nov 2019]. Available at: http://care.diabetesjournals.org/content/26/3/725.short
  • Bender AM, Jørgensen T, Helbech B, et al. Socioeconomic position and participation in baseline and follow-up visits: the Inter99 study. Eur J Prev Cardiol. 2014;21(7):899–905.
  • Kamstrup-Larsen N, Dalton SO, Broholm-Jørgensen M, et al. Using general practitioners to recruit individuals with low socioeconomic position to preventive health checks is feasible: a cross sectional study. Scand J Prim Health Care. 2019;37(3):294–301.
  • WHO. World Health Organization 2004. Obesity: preventing and managing the global epidemic. report of a WHO consultation. WHO Technical Report Series no. 894. [accessed 19 Nov 2019]. Geneva. Available at: https://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/
  • Lombard CB, Deeks AA, Teede HJ. A systematic review of interventions aimed at the prevention of weight gain in adults. Public Health Nutr. 2009;12(11):2236–2246.
  • Koponen P, Borodulin K, Lundqvist A, et al. Health, functional capacity and welfare in Finland – FinHealth 2017 study (abstract in English). National Institute for Health and Welfare (THL). [Accessed 19 Nov 2019]. Available at: http://urn.fi/URN:ISBN:978-952-343-105-8
  • Gray DJP, Sidaway-Lee K, White E, et al. Continuity of care with doctors – A matter of life and death? A systematic review of continuity of care and mortality. BMJ Open. 2018;8:1–12.
  • Ebrahim S, Taylor F, Ward K, et al. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011;1:CD001561.
  • Jørgensen T, Jacobsen RK, Toft U, et al. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ. 2014;348:g3617.
  • Skaaby T, Jørgensen T, Linneberg A. Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. Int J Epidemiol. 2017;46(2):603–611.
  • Pennant M, Davenport C, Bayliss S, et al. Community programs for the prevention of cardiovascular disease: A systematic review. Am J Epidemiol. 2010;172(5):501–516.
  • Lee H, Cho J, Shin DW, et al. Association of cardiovascular health screening with mortality, clinical outcomes, and health care cost: A nationwide cohort study. Prev Med. 2015;70:19–25.
  • Fujino Y, Tanabe N, Honjo K, et al.; JACC Study Group. Interest in health screening as a predictor of long-term overall mortality: multilevel analysis of a Japanese national cohort study. Prev Med. 2011;52(1):78–83.